UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported):
| (Exact name of registrant as specified in its charter) | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
|
| ||
| (Address of principal executive offices) (Zip Code) | ||
| ( | ||
| (Registrant’s Telephone Number, Including Area Code) | ||
| Not Applicable | ||
| (Former Name or Former Address, if Changed Since Last Report) | ||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Section 5 — Corporate Governance and Management
| Item 5.07. | Submission of Matters to a Vote of Security Holders. |
At the Annual Meeting of Shareholders (the “Annual Meeting”) of AMN Healthcare Services, Inc. (the “Company”) held on April 19, 2024, the Company’s shareholders voted on four proposals as set forth below, each of which is described in greater detail in the Company’s proxy statement filed on March 5, 2024 for the Annual Meeting (the “Proxy Statement”). The number of votes cast for and against, and the number of abstentions and broker non-votes with respect to each matter voted upon are set forth below.
| 1. | The individuals listed below were elected at the Annual Meeting by the vote set forth in the table immediately below to serve as directors of the Company until the next annual meeting of shareholders or until each of their respective successors have been duly elected and qualified: |
| Directors | For | Against | Abstain | Broker Non-Votes | ||||||
| Jorge A. Caballero | 33,132,881 | 115,452 | 28,411 | 1,640,788 | ||||||
| Mark G. Foletta | 32,655,546 | 593,946 | 27,252 | 1,640,788 | ||||||
| Teri G. Fontenot | 33,177,889 | 70,207 | 28,648 | 1,640,788 | ||||||
| Cary S. Grace | 32,705,987 | 539,333 | 31,424 | 1,640,788 | ||||||
| R. Jeffrey Harris | 32,440,818 | 808,275 | 27,651 | 1,640,788 | ||||||
| Daphne E. Jones | 33,153,836 | 95,103 | 27,805 | 1,640,788 | ||||||
| Sylvia D. Trent-Adams | 33,089,341 | 158,618 | 28,785 | 1,640,788 | ||||||
| Douglas D. Wheat | 31,796,367 | 1,453,289 | 27,088 | 1,640,788 |
| 2. | The approval, on an advisory basis, of the compensation awarded to the Company’s named executive officers, as described in the Proxy Statement. This proposal was approved as set forth immediately below: |
| For | Against | Abstain | Broker Non-Votes | |||||
| 31,193,222 | 2,035,138 | 48,384 | 1,640,788 |
| 3. | The ratification of the selection of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. This proposal was approved as set forth immediately below: |
| For | Against | Abstain | Broker Non-Votes | |||||
| 34,172,443 | 723,487 | 21,602 | - |
| 4. | The approval of a proposed amendment and restatement of the Company’s Amended and Restated Certificate of Incorporation to provide for exculpation of certain officers of the Company from personal liability under certain circumstances as permitted by Delaware law. |
| For | Against | Abstain | Broker Non-Votes | |||||
| 27,966,054 | 5,264,936 | 45,754 | 1,640,788 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| AMN Healthcare Services, Inc. | |||
Date: April 22, 2024 |
By: | /s/ Cary Grace | |
| Name: | Cary Grace |
||
| Title: | Chief Executive Officer | ||
Cover |
Apr. 19, 2024 |
|---|---|
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Apr. 19, 2024 |
| Entity File Number | 001-16753 |
| Entity Registrant Name | AMN HEALTHCARE SERVICES, INC. |
| Entity Central Index Key | 0001142750 |
| Entity Tax Identification Number | 06-1500476 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 2999 Olympus Boulevard |
| Entity Address, Address Line Two | Suite 500 |
| Entity Address, City or Town | Dallas |
| Entity Address, State or Province | TX |
| Entity Address, Postal Zip Code | 75019 |
| City Area Code | 866 |
| Local Phone Number | 871-8519 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, par value $0.01 per share |
| Trading Symbol | AMN |
| Security Exchange Name | NYSE |
| Entity Emerging Growth Company | false |
-8?20$3;8T.P
M6BP^0"X99K>]9!:G